Topical diclofenac containing products are indicated for the treatment of inflammatory and painful conditions.
Amarin has under development a topical gel of diclofenac sodium 1%, and a topical patch of diclofenac sodium 1%.
Amarin is willing to consider a range of partnership options for these transdermal formulations.
Amarin is engaged in the development of innovative pharmaceutical products using its proprietary topical and transdermal drug delivery technologies and know-how.
View profile